Trio of Phase I Studies Investigates Mesothelin-Directed CAR T-Cell Therapies

At the American Association for Cancer Research Annual Meeting, researchers presented data from three separate phase I studies investigating distinct mesothelin-targeted chimeric antigen receptor T-cell therapies: SynKIR-110, UCMYM802, and M28z1XXPD1DNR.

Publication Details

Journal
Cancer Discovery
Published
2026-04-30
DOI
https://doi.org/10.1158/2159-8290.cd-nw2026-0049
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trio of Phase I Studies Investigates Mesothelin-Directed CAR T-Cell Therapies

Cancer Discovery
CAR-T cell therapy research
article

Trio of Phase I Studies Investigates Mesothelin-Directed CAR T-Cell Therapies

article en

Abstract

At the American Association for Cancer Research Annual Meeting, researchers presented data from three separate phase I studies investigating distinct mesothelin-targeted chimeric antigen receptor T-cell therapies: SynKIR-110, UCMYM802, and M28z1XXPD1DNR.

Cancer Discovery
Good health and well-being
Openalex Percentile: Top 14%
CAR-T cell therapy research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.